Abstract Details

Title Utility of Pelvic MRV in Evaluation of Patients with Cryptogenic Stroke and PFO

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 228

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Marcey L. Osgood, DO PRESENTER	No disclosure on file
Elizabeth R. Budman, MD	No disclosure on file
Nils Henninger, MD, PhD, FANA (UMass Memorial Medical Center)	Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. The institution of Dr. Henninger has received research support from DoD. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Myrobalan Inc.
	No disclosure on file